Short duration radiotherapy in stage I seminoma of the testis: preliminary results of a prospective study.
Ninety-four patients with Stage I seminoma of the testis, treated between November 1989 and December 1991, received short duration radiotherapy (2000 cGy in 8 fractions) to the para-aortic area only. The treatment was well tolerated and, after a median follow-up time of 34 months (minimum 15 months), no patient has relapsed in the abdomen. One patient developed an apparently solitary distant metastasis from a latent teratoma and is disease free after chemotherapy. This form of radiotherapy would appear to be well-tolerated with a low relapse rate. It offers the advantage of a simpler and shorter technique compared with conventional therapy and avoids the necessity of intensive surveillance to detect relapse.
Read
G
G
Department of Radiotherapy, Christie Hospital, Manchester, UK.
Johnston
R J
RJ
D000328:Adult; D000368:Aged; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011446:Prospective Studies; D011879:Radiotherapy Dosage; D018239:Seminoma / Q000473:pathology / Q000532:radiotherapy*; D013736:Testicular Neoplasms / Q000473:pathology / Q000532:radiotherapy*; D016896:Treatment Outcome